Glioma INDIGO Phase 3 Trial Vorasidenib in Patients with an IDH1 or IDH2 Mutation Brain 3 Mins Read14 Karan Dixit, MD, from Northwestern Medicine, delivered a compelling presentation during the Plenary Session at the recent conference on glioma…
